Home » Regional Activities » North America » US Legislative Advocacy » Accomplishments
Accomplishments
The Global Campaign was founded in 1998, when few US public officials, either within the Administration or on Capitol Hill, had ever heard the word “microbicide”, and even fewer were familiar with its public health implications. Today, however, both the word and the issues around microbicides are routinely integrated into policy discussions and legislation addressing the epidemic, such that:
1. Key individuals in leadership positions are more frequently citing microbicides as a potential HIV prevention tool that requires increased and sustained resources for research and development.
2. The Office of AIDS Research at the National Institutes of Health must now submit annual written reports on all Federal expenditures for microbicide research and development to the appropriate House and Senate committees.
3. NIH was required to take the lead in coordinating other Federal agencies in creation of a "Federal Strategic Plan for Microbicide Research and Development.” (link to objectives of the plan)
4. Total US Federal funding for microbicide research and development rose from just under $35 million in FY2000 to over $139 million for FY2007. Click here to see a 
report on HIV prevention expenditures.
- Globally, total investment in microbicide research and development has grown from $65.1 million in 2000 to over $225 million in 2007.
- The United States is the biggest public contributor to microbicides development, providing over $139 million, or about 62% of total funding.
- USAID’s microbicide development program grew from approximately $2.1 million to $22 million in FY2004. CDC’s microbicide program has grown by several million dollars over that same time period as the US Congress has explicitly stated its support for this research in annual appropriations bills and reports.
5. On July 30, 2008, President Bush signed into law the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization Act of 2008. This law reauthorizes the President’s Emergency Plan for AIDS Relief (PEPFAR), marking a significant step in addressing these three global health challenges. The new five-year, $48 billion plan expands access to existing lifesaving prevention, treatment, and care services for those most in need. It also expands support for the research and development of health technologies such as new drugs, vaccines, and microbicides. The law contains positive language surrounding the development of microbicides as an integral component in HIV prevention efforts. To read the law, click here.
For more information on the history of legislative advocacy on microbicides, visit our Archives.
